文献速递腹部介入CT

基于增强CT参数的可解释机器学习模型预测肝细胞癌患者对常规经动脉化疗栓塞的治疗反应

An interpretable machine learning model based on contrast-enhanced CT parameters for predicting treatment response to conventional transarterial chemoembolization in patients with hepatocellular carcinoma.
PubMed 文献 · Radiol Med · 2024-02-14

这项回顾性多中心研究纳入367例接受cTACE作为一线治疗的中期肝细胞癌患者,测量多期增强CT的平均衰减值并计算动脉、门静脉及动脉门静脉增强比,构建三种机器学习模型。整合CT参数与临床变量的随机森林模型在外部队列验证中AUC达0.800,可将患者分为生存期不同的应答者与无应答者(P=0.001)。

要点

  • RF联合模型外部验证AUC为0.800,可区分cTACE应答者与无应答者。
  • CT参数加入临床变量后预测性能显著提升,净重分类指数为0.318(P<0.001)。
  • 模型分层后两组生存期差异有统计学意义(P=0.001)。

核心结论

  • RF联合模型可作为稳健且可解释的工具,识别适合cTACE治疗的人群,使患者免于接受无效且不必要的治疗。

研究设计与样本

  • 回顾性研究,纳入三个中心367例接受cTACE作为一线治疗的中期肝细胞癌患者,测量多期增强CT目标病灶平均衰减值并计算AER、PER、APR,采用logistic回归筛选特征,通过5折交叉验证训练三种机器学习模型,以判别力、校准度和临床效用评估预测治疗反应的表现。

诊断标准与关键数值

  • RF联合模型(整合CT参数与临床变量)在外部队列验证中AUC为0.800;CT参数加入临床变量后净重分类指数0.318(P<0.001);模型分层后应答者与无应答者生存期差异P=0.001。

临床应用与阅片要点

  • 作者认为RF联合模型可识别适合cTACE治疗的人群,使患者免于接受无效且不必要的治疗;模型输出经SHAP算法解释。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To explore the potential of pre-therapy computed tomography (CT) parameters in predicting the treatment response to initial conventional TACE (cTACE) in intermediate-stage hepatocellular carcinoma (HCC) and develop an interpretable machine learning model.

METHODS: This retrospective study included 367 patients with intermediate-stage HCC who received cTACE as first-line therapy from three centers. We measured the mean attenuation values of target lesions on multi-phase contrast-enhanced CT and further calculated three CT parameters, including arterial (AER), portal venous (PER), and arterial portal venous (APR) enhancement ratios. We used logistic regression analysis to select discriminative features and trained three machine learning models via 5-fold cross-validation. The performance in predicting treatment response was evaluated in terms of discrimination, calibration, and clinical utility. Afterward, a Shapley additive explanation (SHAP) algorithm was leveraged to interpret the outputs of the best-performing model.

RESULTS: The mean diameter, ECOG performance status, and cirrhosis were the important clinical predictors of cTACE treatment response, by multiple logistic regression. Adding the CT parameters to clinical variables showed significant improvement in performance (net reclassification index, 0.318, P < 0.001). The Random Forest model (hereafter, RF-combined model) integrating CT parameters and clinical variables demonstrated the highest performance on external validation dataset (AUC of 0.800). The decision curve analysis illustrated the optimal clinical benefits of RF-combined model. This model could successfully stratify patients into responders and non-responders with distinct survival (P = 0.001).

CONCLUSION: The RF-combined model can serve as a robust and interpretable tool to identify the appropriate crowd for cTACE sessions, sparing patients from receiving ineffective and unnecessary treatments.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Zhang L, Jin Z, Li C, et al. An interpretable machine learning model based on contrast-enhanced CT parameters for predicting treatment response to conventional transarterial chemoembolization in patients with hepatocellular carcinoma. Radiol Med. 2024. PMID: 38353864. doi:10.1007/s11547-024-01785-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。